Wilmington-Based Pharmaceutical Company Says Bankruptcy Possible

Pharmaceutical company aaiPharma is considering filing for Chapter 11 bankruptcy protection in order to stay in business while it repays $350 million in bond and credit debt. Chief executive officer Ludo Reynders and chief financial officer Matthew Czajkowski expect to make a decision before April 30, when the grace period expires for several debt commitments, according to government filings.

Big News Network (http://feeds.bignewsnetwork.com/redir.php?jid=a133b59bf87cf254&cat=6dcd932030878143)